A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2002
11/06/2002	EP1254264A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
11/06/2002	EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/06/2002	EP1254241A2 Phosphatases
11/06/2002	EP1254240A2 Proteins producing an altered immunogenic response and methods of making and using the same
11/06/2002	EP1254236A2 Drug metabolizing enzymes
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/06/2002	EP1254224A2 Interferon-alpha induced genes
11/06/2002	EP1254214A2 Human protein kinases and protein kinase-like enzymes
11/06/2002	EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002	EP1254180A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody
11/06/2002	EP1254176A2 Trade molecules and uses related thereto
11/06/2002	EP1254169A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity
11/06/2002	EP1254168A2 Cytokine inhibittory molecules from tick salivary glands
11/06/2002	EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002	EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002	EP1254130A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/06/2002	EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1254111A1 Novel vitamin d analogues
11/06/2002	EP1253947A2 Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
11/06/2002	EP1253946A2 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
11/06/2002	EP1253942A1 Cd40-binding apc-activating molecules
11/06/2002	EP1253941A1 Pre-transplant accommodated organs resistant to anti-donor immunity
11/06/2002	EP1253940A2 Low dose haptenized tumor cell and tumor cell extract immunotherapy
11/06/2002	EP1253939A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
11/06/2002	EP1253930A2 Method and compositions for treating hepatocellular cancer
11/06/2002	EP1253923A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002	EP1109818B1 Phosphoepoxides, method for making same and uses
11/06/2002	EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002	EP0865297B1 Vaccine compositions for intranasal administration comprising chitosan and use thereof
11/06/2002	EP0784476B1 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and optionally a vitamin b 12 compound
11/06/2002	EP0726758B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
11/06/2002	CN1378591A Bacterial protection
11/06/2002	CN1378560A Compounds for treatment of infectious and immune system disorders and method for their use
11/06/2002	CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002	CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002	CN1378460A Skin immune function controlling agents
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1378455A Use of diterpenoid triepoxides as anti-proliferative agent
11/06/2002	CN1378445A Drug releasing biodegradable fiber implant
11/06/2002	CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/06/2002	CN1093852C 维生素ｄ酰胺衍生物 Amide derivatives of vitamin d
11/05/2002	US6476236 Synthesis of 2-cyanoaziridine-1-carboxamide
11/05/2002	US6476209 Polynucleotides, materials incorporating them, and methods for using them
11/05/2002	US6476201 Methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
11/05/2002	US6476197 Polypeptides having interferon-γ inducing activity
11/05/2002	US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002	US6476052 Isoindolines, method of use, and pharmaceutical compositions
11/05/2002	US6476028 Compounds and methods
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6476022 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
11/05/2002	US6476020 Imidazo-benzazepine compounds, their compositions and uses
11/05/2002	US6476000 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
11/05/2002	US6475997 Methods of stimulating phagocytosis
11/05/2002	US6475995 Oral delivery of nucleic acid vaccines by particulate complexes
11/05/2002	US6475986 Uses of THANK, a TNF homologue that activates apoptosis
11/05/2002	US6475524 Composition of matter
11/05/2002	US6475519 Oil-free pharmaceutical compositions containing cyclosporin A
11/05/2002	US6475493 Controlled release pellet formulation
11/05/2002	US6475483 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens for treating autoimmune diseases
11/05/2002	US6475480 Use of adenoviral E4 reading frames to improve expression of a gene of interest
11/05/2002	US6475467 Medicinal aerosol formulations
11/05/2002	CA2109322C Bombesin analogs
11/05/2002	CA2091449C Cloning and sequencing of allergens of dermatophagoides (house dust mite)
11/05/2002	CA1341396C Cyclosporin crystal form, processes for its production pharmaceutical compositions containing it and its use
10/2002
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086105A1 Delivery of polynucleotide agents to the central nervous sysstem
10/31/2002	WO2002086102A1 Lactic acid bacteria as agents for treating and preventing allergy
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002	WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002	WO2002085941A2 Modified interferon alpha with reduced immunogenicity
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085905A1 Novel adenine derivatives
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085897A1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002	WO2002085887A1 Phenyl- and pyridyl-piperidines with tnf activity
10/31/2002	WO2002085868A1 Benzoxazinone derivatives for use in the treatment of angiogenesis
10/31/2002	WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085447A2 Microprojection array having a beneficial agent containing coating
10/31/2002	WO2002085410A2 Method for evaluating the efficacy of treatment with bacterial dna and bacterial cell walls
10/31/2002	WO2002085368A2 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
10/31/2002	WO2002085337A1 Micellar drug delivery systems for hydrophobic drugs

1 ... 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 ... 1172